However, the relationship between BRCA1 and EC has been complicated by the fact that tamoxifen, prescribed for BC treatment, is known to increase the risk of developing type I EC,24 and it is currently unclear whether HDR gene variants constitute tamoxifen‐independent risk factors. This evidence concerns the gene BRCA1 and breast cancer.